The Sentence Labcorp Asked MolDX to Strike
On August 10 the four MolDX contractors turned on Medicare's first coverage policy for MASH fibrosis blood tests, naming five tests and conditioning every one of them on a FIB-4 result, an elastography lookback and a technical assessment. Seven weeks later Labcorp gets a national code for a sixth test that is on none of the four code lists, and the criterion standing in its way is the one Labcorp asked to have struck.
On October 1, Labcorp gets a national code for a MASH blood test called NIS2+.
Seven weeks earlier, the four Medicare contractors that would have to pay for it finished turning on the first coverage policy Medicare has ever written for MASH fibrosis blood tests.
NIS2+ is not on it.
The rest of this brief is for subscribers.
The impact tables, the code-level detail, and the rest of the analysis sit past this line.
$50 a month, or $500 a year.
Already a subscriber? Sign in